Ted Judd

From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)

Yuan Cheng, Ted Judd, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2011 · 136 citations · Full text

STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells

Carol Babij, Yihong Zhang, Robert J. Kurzeja et al. · Cancer Research · 2011 · 126 citations · Full text

Kras Mutations, Cancer Research, Stk33 Kinase +14

Fragment-Linking Approach Using ¹⁹ F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase

John B. Jordan, Douglas A. Whittington, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2016 · 71 citations · Full text

Concise Enantioselective Synthesis of (+)‐FR66979 and (+)‐FR900482: Dimethyldioxirane‐Mediated Construction of the Hydroxylamine Hemiketal

Ted Judd, Robert M. Williams · Angewandte Chemie International Edition · 2002 · 68 citations

Bioorganic Chemistry, Unique Hydroxylamine Hemiketal, Organic Chemistry +19

Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid

Matthew M. Weiss, Toni Williamson, Safura Babu‐Khan et al. · Journal of Medicinal Chemistry · 2012 · 63 citations · Full text